NLS Pharmaceuticals
Manufacturing · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
The Cir 6, Zürich, Zurich, 8058, Switzer...Phone Number
+41 445122150Website
www.nlspharma.comRevenue
-Stock Symbol
NLSPIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About NLS Pharmaceuticals
NLS Pharmaceutics is a clinical-stage drug development company. Their R&D Focus is based on neurobehavioral and neurocognitive disorders and their pharmacognosia. NLS Pharmaceutics is based out of Nidwalden, Switzerland.Explore more
NLS Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NLS Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once NLS Pharmaceuticals has new funding data
Check out if NLS Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on NLS Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at NLS Pharmaceuticals
Click to see if NLS Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when NLS Pharmaceuticals launches new products
Check if NLS Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
NLS Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at NLS Pharmaceuticals
Find more new buyers
Company Profile Activity
Activity Insights
NLS Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NLS Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NLS Pharmaceuticals.
NLS Pharmaceuticals financials insights
Gather financial insights about NLS Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Share Placement
$3M
Private Equity
$1M
NLS Pharmaceuticals Tech Stack
A closer look at the technologies used by NLS Pharmaceuticals
Most Recent Scoops
Partnership
Partnership, Product Management, Medical Research, Pharmaceuticals
Funding
, according to a recent Form D filing, has secured $1,000,000 in Private Equity funding.
Funding
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
NLS Pharmaceuticals News & Media
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
Combined Company Re-Named NewcelX Ltd., to Commence Trading on the Nasdaq Capital Market on October 31, 2025 under the Ticker Symbol "NCEL" ZURICH and NESS ZIONA, Israel , Oct. 30, 2025 /PRNewswire/ -- NewcelX Ltd. ("NewcelX" or the "Company") completed the previously announced merger...NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs
DOXA Platform Expansion Strengthens Cognitive, Arousal, and Neuroprotective Programs Supported by Solid Cash Position and Strategic Funding Outlook ZURICH, Oct. 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP)(Nasdaq: NLSPW) ("NLS"), a Swiss clinical-stage biopharmaceutical...NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation Support for ITOL-102 Diabetes Program Following Merger
ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS" or the "Company"), a biopharmaceutical company focused on developing innovative therapies for central nervous system and neurodegenerative disorders, and Kadimastem Ltd. (TASE: KDST) ("Kadimastem"), a...NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem
ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NLS Pharmaceuticals
Sign Up For FreeTo access detailed company insights
NLS Pharmaceutics is a clinical-stage drug development company. Their R&D Focus is based on neurobehavioral and neurocognitive disorders and their pharmacognosia. NLS Pharmaceutics is based out of Nidwalden, Switzerland.... Read More
